MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CUE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cue Biopharma (CUE) Ownership - Who owns Cue Biopharma?

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
40 Guest Street
Phone
+1 617 949-2680
Employees
29
Web
https://www.cuebiopharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
209.36M
P/E Ratio
N/A
Total Cash
17.39M
Projected Growth
N/A
Total Debt
3.08M
Revenue
37.66M
Risk (Beta)
3.06
Dividend Yield
N/A
Total Cash/Share
2.39
Total Debt/Equity
N/A
Revenue/Share
8.31 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
CUE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for CUE
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
40 Guest Street
Phone
+1 617 949-2680
Employees
29
Web
https://www.cuebiopharma.com
Who owns Cue Biopharma? CUE symbol Ownership - Tickeron.com